HeXun Biosciences Co (ROCO:6986) FCF Margin % : 63.13% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is HeXun Biosciences Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. HeXun Biosciences Co's Free Cash Flow for the six months ended in Dec. 2024 was NT$96.6 Mil. HeXun Biosciences Co's Revenue for the six months ended in Dec. 2024 was NT$153.0 Mil. Therefore, HeXun Biosciences Co's FCF Margin % for the quarter that ended in Dec. 2024 was 63.13%.

As of today, HeXun Biosciences Co's current FCF Yield % is 2.40%.

The historical rank and industry rank for HeXun Biosciences Co's FCF Margin % or its related term are showing as below:

ROCO:6986' s FCF Margin % Range Over the Past 10 Years
Min: 15.53 Med: 20.22 Max: 29.2
Current: 29.2

During the past 5 years, the highest FCF Margin % of HeXun Biosciences Co was 29.20%. The lowest was 15.53%. And the median was 20.22%.

ROCO:6986's FCF Margin % is ranked better than
93.49% of 999 companies
in the Biotechnology industry
Industry Median: -120.51 vs ROCO:6986: 29.20

HeXun Biosciences Co FCF Margin % Historical Data

The historical data trend for HeXun Biosciences Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeXun Biosciences Co FCF Margin % Chart

HeXun Biosciences Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

20.22

15.53

29.20

HeXun Biosciences Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial			61.15	-76.32	40.07	-9.74	63.13

Competitive Comparison of HeXun Biosciences Co's FCF Margin %

For the Biotechnology subindustry, HeXun Biosciences Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeXun Biosciences Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where HeXun Biosciences Co's FCF Margin % falls into.

Save Embed

;

Save Embed

;

HeXun Biosciences Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

HeXun Biosciences Co's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	83.626	/	286.418
	=	29.20 %

HeXun Biosciences Co's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	96.614	/	153.045
	=	63.13 %

HeXun Biosciences Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of HeXun Biosciences Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

HeXun Biosciences Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN

Website

https://www.hexunbio.com

HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.

HeXun Biosciences Co Headlines

No Headlines